Performance-Linked Incentives for Officers and Employees Through Stock Acquisition Rights
First written in FY2020-Q2. 8 of 9 entries say "Advanced", first in FY2020. Latest entry: 2026-07-09.
The whole theme swung hardest in 2020: 2 of 16 companies on the "Worse" side.
11 other companies' latest entry also says "Advanced".
- FY2025-H1AdvancedAnnual report
「From 1 April 2024 to 31 May 2024, the total number of shares issued and outstanding increased by 4,761,400 shares, while capital and the capital reserve each increased by ¥159.122 million, through increases resulting from the exercise of stock acquisition rights and the exercise of stock acquisition rights (stock options).」
The seventh and eighth series of stock acquisition rights and other rights were exercised, resulting in the issuance of 4,761,400 new shares and increases of ¥159.122 million each in capital and the capital reserve. - FY2024AdvancedAnnual report
「7 March 2024 (Note 2) 4,615,384 41,746,384 150,000 1,283,205 150,000 1,053,204」
The Company issued 4,615,384 shares through the exercise of rights attached to convertible bonds with stock acquisition rights, increasing capital and the capital reserve by ¥150 million each. The eighth series of stock acquisition rights, covering 4,615,400 shares, was also disclosed as issued and outstanding. - FY2024-Q2AdvancedAnnual report
「First series of unsecured convertible bonds with stock acquisition rights, approved by the Board of Directors on 10 April 2023 Number of stock acquisition rights: 30 (Common shares: 4,615,384) Eighth series of stock acquisition rights, approved by the Board of Directors on 10 April 2023 Number of stock acquisition rights: 46,154 (Common shares: 4,615,400)」
The disclosed issuance terms for the first series of unsecured convertible bonds with stock acquisition rights and the eighth series of stock acquisition rights covered 4,615,384 and 4,615,400 common shares, respectively, expanding the issuance structure for stock acquisition rights and other instruments, including performance-linked instruments. - FY2023-Q1AdvancedAnnual report
「Based on resolutions of the Board of Directors dated 13 April 2022 and 22 April 2022, the Company allocated and issued stock acquisition rights to the Company's directors and employees, as well as the directors and employees of its subsidiaries. The main terms of each series of stock acquisition rights are as follows.」
The Company issued 5,400 sixth-series stock acquisition rights to 5 directors, covering 540,000 common shares, and 5,500 seventh-series stock acquisition rights to 19 Company employees and subsidiary officers and employees, covering 550,000 common shares. Incentives aimed at expanding performance, increasing corporate value and maximizing corporate value had progressed to the issuance and grant stage. - FY2020AdvancedAnnual report
「Grant date 30 September 2019 Vesting conditions ① The persons allocated the fifth series of stock acquisition rights (the “Trustees”) may not exercise the fifth series of stock acquisition rights. Only persons granted the fifth series of stock acquisition rights by the Trustees (the “Beneficiaries” or “Holders of These Stock Acquisition Rights”) may exercise them.」
The annual report confirms the grant on 30 September 2019 and the outstanding unvested balance for the fourth series of stock acquisition rights covering 600,000 shares and the fifth series covering 1,800,000 shares. The performance-linked incentive had progressed to the post-grant stage. - FY2020-Q2First statedAnnual report
「The exercise conditions for the fifth series of stock acquisition rights provide that a beneficiary may exercise the rights granted to it only if the Company's operating income exceeds ¥1.1 billion in any fiscal year from the fiscal year ending March 2021 through the fiscal year ending March 2025.」
The fifth series of stock acquisition rights introduced a performance-linked incentive requiring operating income above ¥1.1 billion in at least one fiscal year from the fiscal year ending March 2021 through the fiscal year ending March 2025.